Versiti Blood Health, Inc.

Milwaukee, WI Doing business as Versiti Wisconsin Inc.

UEI
JZDRNT166LE4
CAGE
3HFE0
Primary NAICS
621991 Blood and Organ Banks
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Non-Profit Organization
Entity structure
Corporate Entity (Tax Exempt)
Corporate family
SAM.gov registration date
Physical address
638 N 18th St, Milwaukee, WI 53233, USA
Website
versiti.org
Founded
1947
Employees
1K-5K
Estimated annual revenue
$500M-$1B
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
  4. Health Care Services
SIC code
80 Health Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $2,633,231
FY2026 $3,758,764
FY2025 $2,426,476
FY2024 $6,282,751
FY2023 $6,855,057

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Veterans Affairs $5,402,956
2 Department of Health and Human Services $989,039

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Grant awards

Latest 5 listed here. See the rest on GovTribe.

Grant subawards

Prime recipient Prime award Amount Awarded
The Medical College Of Wisconsin, Inc. Platelet-derived FVIII Gene Therapy of Hemophilia A R01HL102035 $259,258
The Medical College Of Wisconsin, Inc. Biobehavioral Oncology Training Program T32CA269115 $86,271
The Medical College Of Wisconsin, Inc. Regulating FoxA-Mediated Transcription during Liver Development R01DK145591 $36,246
The Medical College Of Wisconsin, Inc. The role of tPA in reducing Lp(a) assembly R01HL184418 $346,168
The Medical College Of Wisconsin, Inc. NKA/CD36 Signaling in Adipocytes Promotes Oxidative Stress and Drives Chronic Inflammation in Atherosclerosis R01HL164460 $203,037

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

Vendor Location Primary NAICS
Vitalant Research Institute UEI GKT4L2JZJ622 Scottsdale, AZ 621511 Medical Laboratories
Lifesouth Community Blood Centers Inc. UEI JXA3FSKNMXZ3 Gainesville, FL 621991 Blood and Organ Banks
Stbtc UEI J4UKR8JY4L54 San Antonio, TX 621991 Blood and Organ Banks
Puget Sound Blood Center And Program UEI ZN56PFWUDQK7 Seattle, WA 621991 Blood and Organ Banks
The Blood Center UEI SCFJBJWLMXT6 New Orleans, LA 621991 Blood and Organ Banks

About the company

Versiti Blood Health, Inc., doing business as Versiti Wisconsin Inc., is a non-profit blood center and transfusion medicine organization that supplies blood collection, processing, testing, storage, and distribution services to the Department of Veterans Affairs healthcare system and federal research agencies as a prime contractor on nearly all of its federal work. The organization holds 516 prime awards (92% of recent activity) spanning contracts, indefinite-delivery vehicles, and federal grants, with 558 total awards across 26 federal customer agencies and combined potential value of $216.1 million.

Versiti's federal customer base is dominated by the Department of Veterans Affairs Veterans Integrated Service Network 12, which accounts for 150 awards worth $127.3 million in combined potential value—59% of the vendor's prime portfolio and roughly 59% of total awards. The National Heart, Lung, and Blood Institute follows at 68 awards worth $40.1 million. Together, these two customers anchor 81% of the vendor's combined potential value across all federal sources. The VA concentration reflects recurring firm fixed-price delivery orders for blood and blood products issued against single-award indefinite-delivery contracts; Versiti holds at least five VA IDC vehicles, with the largest carrying a $10.7 million ceiling through September 2031 and generating 49 task orders worth $17 million in combined potential value. Recent VA delivery orders from October 2026 total $1.8 million and $814,000 across two newly awarded IDCs covering six VISN 12 medical facilities (Chicago, North Chicago, Hines Illinois; Madison and Tomah Wisconsin; and Milwaukee).

Versiti's research and development portfolio centers on transfusion medicine, blood safety, platelet biology, hemostasis, thrombosis, and hematologic disease. The organization operates the Blood Research Institute as its translational research arm and holds a portfolio of NIH research grants anchored by the National Heart, Lung, and Blood Institute and the National Institute of Diabetes and Digestive and Kidney Diseases. Recent prime research awards include a $6.758 million NHLBI delivery order under the Recipient Epidemiology and Donor Evaluation Study (REDS) Regional Hubs program (cost-no-fee pricing, through September 2033); a $1.409 million NIDDK grant on fetal hemoglobin distribution in sickle cell disease (July 2026–April 2031); a $1.069 million NHLBI grant on kindlin-3 signaling in platelets and neutrophils (March 2026–December 2032); and a $6.485 million Defense Health Agency definitive contract for research and development on counterflow hemostatic gauze for extreme cold environments (September 2023–December 2026), with subcontractors St. Michael's Hospital and Comotion Drug Delivery Systems Inc. The organization also acts as a sub-recipient under Medical College of Wisconsin and other institution prime grants, with named sub-awards in genomics, hematology, immunology, and gene therapy research.

Activity has grown modestly—13 awards in 2022 to 30 in 2024, with a slight contraction to 25 in 2026. Twenty-three awards with combined potential value of $10.8 million reach ultimate completion in the next twenty-four months, creating near-term recompete exposure in both VA blood supply and NIH research portfolios. SCI-reported invoiced revenue from federal service contracts above the $150,000 threshold totaled $3.8 million from FY2022 through FY2025, with median government-paid hourly rates around $130.21/hr and a 7% average share of sub-hours across prime contracts, indicating that Versiti builds most delivery internally with light subcontractor engagement. The vendor holds a 92% prime vs. 8% sub split, with sub work primarily routed through grant sub-awards to academic and research institutions including the Medical College of Wisconsin, the Children's Hospital of Philadelphia, and universities across the country.

Versiti Blood Health is structured as a non-profit tax-exempt entity with two named subsidiaries: Versiti Indiana, Inc., also a non-profit, and Quantigen, LLC, a limited liability company. No federal set-asides apply across the vendor's award footprint; all work is full-and-open competitive.

Quick answers

Is Versiti Blood Health, Inc. registered in SAM.gov?

Yes. Versiti Blood Health, Inc.'s SAM.gov registration is active through January 8, 2027.

How much has Versiti Blood Health, Inc. received in federal contracts?

Federal contracts obligated $2,426,476 to Versiti Blood Health, Inc. in fiscal year 2025 and $21,956,279 in fiscal years 2023 through 2027.

How does Versiti Blood Health, Inc. rank among federal contractors?

Versiti Blood Health, Inc. ranked #12 in NAICS 325414, #16 in NAICS 621991 and #51 in PSC 6505 in FY2025.

What is Versiti Blood Health, Inc.'s most recent federal award?

Versiti Blood Health, Inc.'s most recent federal contract award is E0 14398 - reference lab testing service (36C25627N0203), from Veterans Integrated Service Network 16 (VHA), on November 2, 2026.

On GovTribe

See Versiti Blood Health, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors